The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single- center study

被引:1
|
作者
Lee, Doo-Ho [1 ]
Park, Yeon Ho [1 ]
Choi, Seok Won [1 ]
Nam, Kug Hyun [1 ]
Choi, Sang Tae [1 ]
Kim, Doojin [1 ]
机构
[1] Gachon Univ, Gil Med Ctr, Dept Surg, Coll Med, 774-21 Namdong Daero, Incheon 21565, South Korea
关键词
Alcoholic fatty liver; Liver cirrhosis; Liver transplantation; Model for End-Stage Liver Disease; Morbidity; ALLOCATION SYSTEM; MORTALITY;
D O I
10.4174/astr.2021.101.6.360
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: In June 2016, the Model for End-Stage Liver Disease (MELD) score was employed in South Korea instead of the Child-Turcotte-Pugh (CTP) score. This study compared the outcomes of deceased donor liver transplantation (DDLT) before and after the MELD system application. Methods: This retrospective study reviewed 48 patients who underwent DDLT for end-stage liver disease at a single tertiary referral center between January 2014 and December 2018. The patients were categorized into the pre-MELD (22 patients) and post-MELD (26 patients) groups. The demographics, postoperative outcomes, and overall survival time were evaluated between the 2 groups. Results: The 2 groups had no differences in age, sex, ABO type, etiology for liver transplantation, CTP-score, operation time, cold ischemic time, and amount of red blood cell transfusion, although their MELD score differed significantly (post -MELD group, 36.2 +/- 4.9; pre-MELD group, 27.7 +/- 11.8; P < 0.001). The post-MELD group has longer intensive care unit stay (11.2 +/- 9.5 days vs. 5.7 +/- 4.5 days, P = 0.018) and hospital stay than the pre-MELD group (36.8 +/- 26 days vs. 22.8 +/- 9.3 days, P = 0.016). The 1-year survival rate was lower in the post-MELD group (61.5% vs. 86.4%, P = 0.029). Conclusion: After MELD allocation, patients with high MELD scores had increased DDLT and consequently required a longer recovery time, which could negatively affect survival. According to the experience of a small-volume center, these problems were related to both severe organ shortages in South Korea and MELD allocation.
引用
收藏
页码:360 / 367
页数:8
相关论文
共 50 条
  • [31] Impact of nutritional status of Egyptian patients with end-stage liver disease on their outcomes after living donor liver transplantation
    Yosry, Ayman
    Omran, Dalia
    Said, Mohamad
    Fouad, Waleed
    Fekry, Osama
    JOURNAL OF DIGESTIVE DISEASES, 2014, 15 (06) : 321 - 326
  • [32] Outcomes of Liver Transplantation for Porto-Pulmonary Hypertension in Model for End-Stage Liver Disease Era
    Salgia, Reena J.
    Goodrich, Nathan P.
    Simpson, Heather
    Merion, Robert M.
    Sharma, Pratima
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (08) : 1976 - 1982
  • [33] Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score
    Angermayr, B.
    Luca, A.
    Konig, F.
    Bertolini, G.
    Ploner, M.
    Gridelli, B.
    Ulbrich, G.
    Reiberger, T.
    Bosch, J.
    Peck-Radosavljevic, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) : 65 - 71
  • [34] Outcomes of Liver Transplantation for Porto-Pulmonary Hypertension in Model for End-Stage Liver Disease Era
    Reena J. Salgia
    Nathan P. Goodrich
    Heather Simpson
    Robert M. Merion
    Pratima Sharma
    Digestive Diseases and Sciences, 2014, 59 : 1976 - 1982
  • [35] Model of End-Stage Liver Disease Score and Derived Variants Lack Prognostic Ability After Liver Transplantation
    Kaltenborn, Alexander
    Salinas, Ricardo
    Jaeger, Mark D.
    Lehner, Frank
    Sakirow, Larissa
    Klempnauer, Juergen
    Schrem, Harald
    ANNALS OF TRANSPLANTATION, 2015, 20 : 441 - 448
  • [36] Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?
    Li, C.
    Wen, T.
    Yan, L.
    Li, B.
    Wang, W.
    Xu, M.
    Yang, J.
    Wei, Y.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3620 - 3623
  • [37] Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score
    Beal, Eliza W.
    Akateh, Clifford
    Tumin, Dmitry
    Bagante, Fabio
    Black, Sylvester M.
    Washburn, Kenneth
    Azouley, Daniel
    Pawlik, Timothy M.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (04) : 491 - 497
  • [38] Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥40: A retrospective cohort study
    Cardoso, Filipe S.
    Karvellas, Constantine J.
    Kneteman, Norman M.
    Meeberg, Glenda
    Fidalgo, Pedro
    Bagshaw, Sean M.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (04) : 185 - 191
  • [39] Reoperative Complications after Primary Orthotopic Liver Transplantation: A Contemporary Single-Center Experience in the Post-Model for End-Stage Liver Disease Era
    DiNorcia, Joseph
    Lee, Minna K.
    Harlander-Locke, Michael
    Zarrinpar, Ali
    Kaldas, Fady M.
    Yersiz, Hasan
    Farmer, Douglas G.
    Hiatt, Jonathan R.
    Busuttil, Ronald W.
    Agopian, Vatche G.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (05) : 993 - 1000
  • [40] Predicting Outcomes in Trauma Patients With Cirrhosis Using Model for End-Stage Liver Disease Score: A Retrospective Study
    Natkha, Vitaliy P.
    Southerland, Parker
    Almekdash, Mhd Hasan
    Keesair, Rohali
    Dhanasekara, Chathurika S.
    Dissanaike, Sharmila
    AMERICAN SURGEON, 2023, 89 (06) : 2383 - 2390